![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 25, 2019 3:00:18 PM
They have an FDA approval for their basic product and it appears a CE approval should be coming soon. But as has been pointed out - it is a crowded market for basic external and a year on from FDA approval there is still no deal and they were forced to dilute more.
Still - they have been building inventory. Which is worth something even in a bad deal.
To me - the fact that the external was cleared by the FDA lends credence to the notion that the internal - and maybe whole pipeline - should eventually get cleared. It may take a whole lot of more diluting if an external deal can't be cut in 3-5 months...…
But the science seems to be sound. Maybe the f**k-ups can be blamed on Management.....maybe honest human error or things out of their control. Maybe both.
But it is worth more then 15-20 cents a share.
Good luck to all.
I don't think we will see a real run until a deal with revenue is cut.
It may bounce up an down between 15-25 cents a share.
Or a little more.
But if they can cut a revenue producing deal...….
Even just enough to put off major dilution....
Then I think we are back up to where this stock has been in years past.
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM